Research ExplorerPublicationsDiagnosis and Management of Vaccine-Related Thrombosis follo...

Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH

Standard

Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH. / Oldenburg, Johannes; Klamroth, Robert; Langer, Florian; Albisetti, Manuela; von Auer, Charis; Ay, Cihan; Korte, Wolfgang; Scharf, Rüdiger E; Pötzsch, Bernd; Greinacher, Andreas.

In: HAMOSTASEOLOGIE, Vol. 41, No. 3, 06.2021, p. 184-189.

Research output: SCORING: Contribution to journal › SCORING: Review article › Research

Harvard

Oldenburg, J, Klamroth, R, Langer, F, Albisetti, M, von Auer, C, Ay, C, Korte, W, Scharf, RE, Pötzsch, B & Greinacher, A 2021, 'Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH', HAMOSTASEOLOGIE, vol. 41, no. 3, pp. 184-189. https://doi.org/10.1055/a-1469-7481

APA

Oldenburg, J., Klamroth, R., Langer, F., Albisetti, M., von Auer, C., Ay, C., Korte, W., Scharf, R. E., Pötzsch, B., & Greinacher, A. (2021). Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH. HAMOSTASEOLOGIE, 41(3), 184-189. https://doi.org/10.1055/a-1469-7481

Vancouver

Oldenburg J, Klamroth R, Langer F, Albisetti M, von Auer C, Ay C et al. Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH. HAMOSTASEOLOGIE. 2021 Jun;41(3):184-189. https://doi.org/10.1055/a-1469-7481

Bibtex

@article{9816e473262a47b1ad44af4d2bd566f3,
title = "Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH",
abstract = "The COVID-19 pandemic is an ongoing global healthcare crisis. Based on reports of atypically located thromboses following vaccination with the AstraZeneca COVID-19 vaccine, the Society of Thrombosis and Haemostasis Research (GTH) has issued guidance statements on the recognition, diagnosis, and treatment of this rare complication. It shares pathophysiological features with heparin-induced thrombocytopenia (HIT) and is referred to as vaccine-induced prothrombotic immune thrombocytopenia (VIPIT).",
keywords = "COVID-19/pathology, COVID-19 Vaccines/administration & dosage, Guidelines as Topic, Heparin/adverse effects, Humans, Purpura, Thrombocytopenic, Idiopathic/diagnosis, Risk Factors, SARS-CoV-2/isolation & purification, Thrombosis/diagnosis",
author = "Johannes Oldenburg and Robert Klamroth and Florian Langer and Manuela Albisetti and {von Auer}, Charis and Cihan Ay and Wolfgang Korte and Scharf, {R{\"u}diger E} and Bernd P{\"o}tzsch and Andreas Greinacher",
note = "Thieme. All rights reserved.",
year = "2021",
month = jun,
doi = "10.1055/a-1469-7481",
language = "English",
volume = "41",
pages = "184--189",
journal = "HAMOSTASEOLOGIE",
issn = "0720-9355",
publisher = "Schattauer",
number = "3",

}

RIS

TY - JOUR

T1 - Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH

AU - Oldenburg, Johannes

AU - Klamroth, Robert

AU - Langer, Florian

AU - Albisetti, Manuela

AU - von Auer, Charis

AU - Ay, Cihan

AU - Korte, Wolfgang

AU - Scharf, Rüdiger E

AU - Pötzsch, Bernd

AU - Greinacher, Andreas

N1 - Thieme. All rights reserved.

PY - 2021/6

Y1 - 2021/6

N2 - The COVID-19 pandemic is an ongoing global healthcare crisis. Based on reports of atypically located thromboses following vaccination with the AstraZeneca COVID-19 vaccine, the Society of Thrombosis and Haemostasis Research (GTH) has issued guidance statements on the recognition, diagnosis, and treatment of this rare complication. It shares pathophysiological features with heparin-induced thrombocytopenia (HIT) and is referred to as vaccine-induced prothrombotic immune thrombocytopenia (VIPIT).

AB - The COVID-19 pandemic is an ongoing global healthcare crisis. Based on reports of atypically located thromboses following vaccination with the AstraZeneca COVID-19 vaccine, the Society of Thrombosis and Haemostasis Research (GTH) has issued guidance statements on the recognition, diagnosis, and treatment of this rare complication. It shares pathophysiological features with heparin-induced thrombocytopenia (HIT) and is referred to as vaccine-induced prothrombotic immune thrombocytopenia (VIPIT).

KW - COVID-19/pathology

KW - COVID-19 Vaccines/administration & dosage

KW - Guidelines as Topic

KW - Heparin/adverse effects

KW - Humans

KW - Purpura, Thrombocytopenic, Idiopathic/diagnosis

KW - Risk Factors

KW - SARS-CoV-2/isolation & purification

KW - Thrombosis/diagnosis

U2 - 10.1055/a-1469-7481

DO - 10.1055/a-1469-7481

M3 - SCORING: Review article

C2 - 33822348

VL - 41

SP - 184

EP - 189

JO - HAMOSTASEOLOGIE

JF - HAMOSTASEOLOGIE

SN - 0720-9355

IS - 3

ER -